We have elucidated the role of FOXM1 in regulating cellular proliferation and tumor growth in EAC patient-derived organoids and cell lines and identified ERBB2 signaling as an upstream regulator of FOXM1. This evidence concerns the gene ERBB2 and neoplasm.